| SESSION NAME |
ASAM (Pharmacists, Pyschologists, Physicians, Physicians Assistants) |
ASWB (Social Worker) |
NEMSD (Nurses) |
NAADAC (Counselor) |
| SATURDAY | ASAM | ASWB | NEMSD | NAADAC |
| The Certified Medication Assistd Treatment Advocate (CMA) Training Course (Registration Required) | 0 | 8.0 | 8.0 | 8.0 |
| MAT Waiver Training | 8.5 | 8.5 | 8.5 | 8.5 |
| Romancing the Brain/Conflict Resolution in Recovery (CRR) | 0 | 7.5 | 7.5 | 7.5 |
| Confidentiality and MAT | 3.0 | 3.0 | 3.0 | 3.0 |
| Accreditation | 4.0 | 4.0 | 4.0 | 4.0 |
| Triple E for HCV Engagement Education and Eradication | 4.0 | 4.0 | 4.0 | 4.0 |
| SUNDAY | ASAM | ASWB | NEMSD | NAADAC |
| Opioid Maintenance Pharmacotherapy: A Course for Clinicians (Registration Required) | 8.0 | 8.0 | 8.0 | 8.0 |
| Long-acting Opioid Agonist Medications: Research and Clinical Practice | 4.0 | 4.0 | 4.0 | 4.0 |
| Transforming Care Delivery: High Reliability in Medication Assisted Treatment | 3.0 | 3.0 | 3.0 | 3.0 |
| Expanding Access to MAT in Correctional Settings | 3.0 | 3.0 | 3.0 | 3.0 |
| Presentations by the World Federation for the Treatment of Opioid Dependence | 4.0 | 4.0 | 4.0 | 4.0 |
| Florida Judges and Court Staff Session (Closed Session) | 4.0 | 4.0 | 4.0 | 4.0 |
| MONDAY | ASAM | ASWB | NEMSD | NAADAC |
| Poster Sessions | 1.25 | 1.25 | 1.25 | 1.25 |
| PL1: Opening Plenary Session: State of Affairs – The Opioid Epidemic | 1.5 | 1.5 | 1.5 | 1.5 |
| A1: Foundations of Medication Assisted Treatment | 1.5 | 1.5 | 1.5 | 1.5 |
| A2: The Criminal Justice System: An Effective Access Point to Treating Opioid Addiction | 1.5 | 1.5 | 1.5 | 1.5 |
| A3: Community Engagement Workshop for Opioid Treatment Programs | 1.5 | 1.5 | 1.5 | 1.5 |
| A4: Practical Methods to Increase Retention in Medication Assisted Treatment | 1.5 | 1.5 | 1.5 | 1.5 |
| A5: A Clinical Conundrum: Pain, Addiction or Both | 1.5 | 1.5 | 1.5 | 1.5 |
| #1: State Actions to Support Provider Innovation: Statutory, Regulatory and Administrative Reform | 1.5 | 1.5 | 1.5 | 1.5 |
| #2: When Disaster Strikes: Partnerships and Strategies for a Coordinated Response to Hurricane Florence | 1.5 | 1.5 | 1.5 | 1.5 |
| #3: Claims Trends and Risk Management in an Increasingly Litigious World | 1.5 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: The Image of MAT and Related Stigma: Challenges and Opportunities | 0 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Using Technology to Improve Care | 1.5 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Medications for Opioid Use Disorders: Which One is Best? | 1.5 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Legal Cannabis in OTPs: Implications for Programs and Treatment Plans | 0 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Insurance Parity (MHPAEA) and Access: An Uncertain Present and Future | 0 | 1.5 | 1.5 | 1.5 |
| Poster Sessions | 1.0 | 1.0 | 1.0 | 1.0 |
| B1: Therapeutic Partnerships: The Most Important Evidence-Based Practice | 1.5 | 1.5 | 1.5 | 1.5 |
| B2: Connecting Community Outpatient Treatment Program to Corrections for Pregnant Patients | 1.5 | 1.5 | 1.5 | 1.5 |
| B3: Improving LGBT+ Care Through Inclusivity: A Community-Based Perspective | 1.5 | 1.5 | 1.5 | 1.5 |
| B4: Community Technical Assistance in Response to the Opioid Epidemic | 1.5 | 1.5 | 1.5 | 1.5 |
| B5: Recovery Coaching in OTPs: Making a Difference | 1.5 | 1.5 | 1.5 | 1.5 |
| TUESDAY | ASAM | ASWB | NEMSD | NAADAC |
| PL2: Middle Plenary Session: A Continuum of Care: The Criminal Justice Role in Treatment | 1.5 | 1.5 | 1.5 | 1.5 |
| C1: Assessment and Treatment for Patients with Co-Occurring Disorders | 1.5 | 1.5 | 1.5 | 1.5 |
| C2: Implementing Medication Assisted Treatment in the Justice System | 1.5 | 1.5 | 1.5 | 1.5 |
| C3: MAT in the Middle of Nowhere: Clever Solutions to a Rural Health Crisis | 1.5 | 1.5 | 1.5 | 1.5 |
| C4: Enhancing Patient Care by Avoiding Burnout and Compassion Fatigue | 1.5 | 1.5 | 1.5 | 1.5 |
| C5: Tackling Stigma Associated with SUDs | 1.5 | 1.5 | 1.5 | 1.5 |
| D1: Group Therapy for Substance Use Disorders: Basics and Beyond | 1.5 | 1.5 | 1.5 | 1.5 |
| D2: Anywhere, Anytime: A Model for Universal Access to Opioid Medication | 1.5 | 1.5 | 1.5 | 1.5 |
| D3: Racial and Ethnic Disparities in OUD: Implications for Cultural-Competence | 1.5 | 1.5 | 1.5 | 1.5 |
| D4: Managing Co-occurring Opioid Use Disorder and Chronic Pain | 1.5 | 1.5 | 1.5 | 1.5 |
| D5: Implementing Telehealth in MAT to Better Serve Rural Areas | 1.5 | 1.5 | 1.5 | 1.5 |
| The Role of Craving and Dual Disorders in Organizing Services for Heroin Addicts | 1.5 | 1.5 | 1.5 | 1.5 |
| WEDNESDAY | ASAM | ASWB | NEMSD | NAADAC |
| E1: Strengthening Trauma Informed Practices Within OTPs | 1.5 | 1.5 | 1.5 | 1.5 |
| E2: Implementing and Sustaining Enhanced MAT in Corrections: Considerations for Diversion, Recidivism and Saving Lives | 1.5 | 1.5 | 1.5 | 1.5 |
| E3: Therapeutic use of Cannabis: Facts, Myths, & Policy Considerations | 1.5 | 1.5 | 1.5 | 1.5 |
| E4: Peer Services for Medication Assisted Treatment (The MARS Project) | 1.5 | 1.5 | 1.5 | 1.5 |
| E5: Resistance or Resilience: Mind and Body Responses | 1.5 | 1.5 | 1.5 | 1.5 |
| F1:Shattering the Stigma and Shedding the Shame | 1.5 | 1.5 | 1.5 | 1.5 |
| F2: Naloxone Distribution in the Opioid Treatment Program Setting | 1.5 | 1.5 | 1.5 | 1.5 |
| F3: Breaking All Barriers: Increasing Access to Care through the Country’s First 24/7 OTP | 1.5 | 1.5 | 1.5 | 1.5 |
| F4: Unleash The Power of Parents & Peers: Engaging & Empowering Families | 1.5 | 1.5 | 1.5 | 1.5 |
| F5: Using Technology to Empower Families and Concerned Others to Support Loved Ones with Opioid Use Disorder | 1.5 | 1.5 | 1.5 | 1.5 |
| PL3: Closing Plenary Session: Combating the Opioid Epidemic as a Nation and around the World | 1.5 | 1.5 | 1.5 | 1.5 |
Like too many New Yorkers, I know what it's like to lose a loved one to addiction—there’s an empty chair at our family table where my nephew, Michael, should be. This is personal for me. Today we’re taking action to combat the opioid epidemic and offer New Yorkers hope. Thread⬇️
#aatod2022 conference
AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014
Contact Us
Phone : 212-566-5555
Email : info@aatod.org
Social Sharing
